Ancora Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.61K | Hold |
34
| – | – | ﹤0.01% | 1525 |
|
2025
Q1 | $4.22K | Hold |
34
| – | – | ﹤0.01% | 1432 |
|
2024
Q4 | $4.19K | Hold |
34
| – | – | ﹤0.01% | 1467 |
|
2024
Q3 | $3.79K | Hold |
34
| – | – | ﹤0.01% | 1455 |
|
2024
Q2 | $3.63K | Hold |
34
| – | – | ﹤0.01% | 1452 |
|
2024
Q1 | $4.09K | Buy |
+34
| New | +$4.09K | ﹤0.01% | 1429 |
|
2023
Q4 | – | Sell |
-55
| Closed | -$7.12K | – | 1745 |
|
2023
Q3 | $7.12K | Hold |
55
| – | – | ﹤0.01% | 1311 |
|
2023
Q2 | $6.82K | Hold |
55
| – | – | ﹤0.01% | 1303 |
|
2023
Q1 | $8.05K | Hold |
55
| – | – | ﹤0.01% | 1289 |
|
2022
Q4 | $9K | Sell |
55
-75
| -58% | -$12.3K | ﹤0.01% | 1326 |
|
2022
Q3 | $17K | Sell |
130
-13
| -9% | -$1.7K | ﹤0.01% | 1340 |
|
2022
Q2 | $22K | Buy |
143
+13
| +10% | +$2K | ﹤0.01% | 1363 |
|
2022
Q1 | $20K | Hold |
130
| – | – | ﹤0.01% | 1517 |
|
2021
Q4 | $17K | Hold |
130
| – | – | ﹤0.01% | 1622 |
|
2021
Q3 | $17K | Buy |
130
+104
| +400% | +$13.6K | ﹤0.01% | 1505 |
|
2021
Q2 | $5K | Buy |
+26
| New | +$5K | ﹤0.01% | 1673 |
|